轉譯醫學博士學位學程

研究成果

每年研究成果 1987 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024

• 49538 引文
• 90 h-指數
• 1916 文章
• 93 回顧型文獻
• 57 社論
• 35 評論/辯論
• 139 更多
  • 34 會議貢獻
  • 29 論文
  • 20 海报
  • 16 章節
  • 15 快報
  • 11 書籍
  • 4 摘要
  • 2 其他
  • 2 Erratum
  • 1 章節（同行評審）
  • 1 會議摘要
  • 1 簡短的問卷調查
  • 1 其他貢獻
  • 1 專利
  • 1 博士論文

每年研究成果

每年研究成果

搜尋結果

• 文章

  A novel method to retrieve alerts from a homegrown Computerized Physician Order Entry (CPOE) system of an academic medical center: Comprehensive alert characteristic analysis

  Chien, S. C., Chin, Y. P. H., Yoon, C. H., Islam, M. M., Jian, W. S., Hsu, C. K., Chen, C. Y., Chien, P. H. & Li, Y. C. J., 2月 2021, 於: PLoS ONE. 16, 2 February, e0246597.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Medical Order Entry Systems 100%
  • physicians 73%
  • Hospital Administrators 38%
  • collectors 37%
  • Programming Languages 19%
  2 引文 斯高帕斯（Scopus）

• A Novel Nonsense Mutation at the Human PTCH Gene in a Patient with Nevoid Basal Cell Carcinoma

  Cheng, K-L., Chang, S-F., Hu, C-H. & Lee, W-R., 2000, 於: Dermatologica Sinica. 18, 3, p. 255-259 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• A novel role for Oct-2 in the lipopolysaccharide-mediated induction of resistin gene expression in RAW264.7 cells

  Lu, S. C., Chang, S. F., Chen, H. L., Chou, Y. Y., Lan, Y. H., Chuang, C. Y., Yu, W. H. & Chen, C. L., 3月 1 2007, 於: Biochemical Journal. 402, 2, p. 387-395 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Resistin 100%
  • Lipopolysaccharides 38%
  • Lipopolysaccharide 38%
  • Gene Expression 26%
  • Octamer Transcription Factors 13%
  10 引文 斯高帕斯（Scopus）

• A novel role for tamoxifen in the inhibition of human platelets

  Chang, Y., Lee, J. J., Chen, W. F., Chou, D. S., Huang, S. Y. & Sheu, J. R., 2月 2011, 於: Translational Research. 157, 2, p. 81-91 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Tamoxifen 100%
  • activation 71%
  • Blood Platelets 57%
  • Platelet Activation 40%
  • aggregation 31%
  16 引文 斯高帕斯（Scopus）

• A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: The pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP

  Lu, W-J., Lee, J. J., Chou, D. S., Jayakumar, T., Fong, T. H., Hsiao, G. & Sheu, J. R., 12月 2011, 於: Journal of Molecular Medicine. 89, 12, p. 1261-1273 13 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • andrographolide 100%
  • Andrographolide 99%
  • Cyclic GMP 74%
  • Nitric Oxide Synthase Type III 72%
  • Platelet Activation 70%
  75 引文 斯高帕斯（Scopus）

• A novel role of sesamol in inhibiting NF-B-mediated signaling in platelet activation

  Chang, C. C., Lu, W-J., Ong, E. T., Chiang, C-W., Lin, S-C., Huang, S. Y. & Sheu, J. R., 2011, 於: Journal of Biomedical Science. 18, 1, 93.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • sesamol 100%
  • Sesamol 89%
  • Platelet Activation 60%
  • Platelet Aggregation 31%
  • Collagen 31%
  37 引文 斯高帕斯（Scopus）

• A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies

  Hsia, C. H., Velusamy, M., Sheu, J. R., Khamrang, T., Jayakumar, T., Lu, W. J., Lin, K. H. & Chang, C. C., 12月 1 2017, 於: Scientific Reports. 7, 1, 9556.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Organometallic Compound 100%
  • Agonist 55%
  • Thrombotic 44%
  • Cyclic Nucleotide 38%
  • Anticoagulant Agent 37%
  14 引文 斯高帕斯（Scopus）

• A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway

  Hsieh, C-L., Huang, H-S., Chen, K-C., Saka, T., Chiang, C-Y., Chung, L. W. K. & Sung, S-Y., 1月 1 2020, 於: Molecular Cancer Therapeutics. 19, 1, p. 101-111 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • salicylanilide 100%
  • Castration 57%
  • Autophagy 49%
  • Prostatic Neoplasms 40%
  • Cell Death 39%
  14 引文 斯高帕斯（Scopus）

• A novel signature of ccnf-associated e3 ligases collaborate and counter each other in breast cancer

  Chang, S. C., Hung, C. S., Zhang, B. X., Hsieh, T. H., Hsu, W. & Ding, J. L., 6月 2 2021, 於: Cancers. 13, 12, 2873.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Ubiquitin-Protein Ligases 100%
  • Breast Neoplasms 55%
  • SKP Cullin F-Box Protein Ligases 48%
  • Neoplasms 23%
  • F-Box Proteins 21%
  11 引文 斯高帕斯（Scopus）

• A novel SNP in the 5' regulatory region of organic anion transporter 1 is associated with chronic kidney disease

  Sun, C. Y., Wu, M. S., Lee, C. C., Chen, S. H., Lo, K. C. & Chen, Y. H., 12月 1 2018, 於: Scientific Reports. 8, 1, 8085.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Organic Anion Transporters 100%
  • Nucleic Acid Regulatory Sequences 80%
  • Chronic Renal Insufficiency 63%
  • Single Nucleotide Polymorphism 58%
  • hepatoma-derived growth factor 41%
  12 引文 斯高帕斯（Scopus）

• A novel tool for visualizing chronic kidney disease associated polymorbidity: A 13-year cohort study in Taiwan

  Huang, C. W., Syed-Abdul, S., Jian, W. S., Iqbal, U., Nguyen, P. A. A. L., Lee, P., Lin, S. H., Hsu, W. D., Wu, M. S., Wang, C. F., Ma, K. L. & Li, Y. C. J. A., 3月 1 2015, 於: Journal of the American Medical Informatics Association. 22, 2, p. 290-298 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Taiwan 100%
  • Chronic Renal Insufficiency 92%
  • Cohort Studies 68%
  • Comorbidity 33%
  • National Health Programs 15%
  23 引文 斯高帕斯（Scopus）

• Anti-apoptotic gene delivery with cyclo-(D-Trp-Tyr) peptide nanotube via eye drop following corneal epithelial debridement

  Lee, Y. H., Chang, S. F. & Liaw, J., 7月 17 2015, 於: Pharmaceutics. 7, 3, p. 122-136 15 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • tryptophyltyrosine 100%
  • Peptide Nanotubes 89%
  • Peptide Nanotube 65%
  • Eye Drop 62%
  • Antiapoptotic 60%
  11 引文 斯高帕斯（Scopus）

• Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures

  Mokgautsi, N., Kuo, Y. C., Tang, S. L., Liu, F. C., Chen, S. J., Wu, A. T. H. & Huang, H. S., 1月 1 2022, 於: Cancers. 14, 1, 262.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Mitogen-Activated Protein Kinase 7 100%
  • Glioblastoma 87%
  • Cell Cycle 70%
  • Cyclin B1 65%
  • Temozolomide 24%
  2 引文 斯高帕斯（Scopus）

• Anticancer effect of curcumin on breast cancer and stem cells

  Liu, H. T. & Ho, Y. S., 6月 2018, 於: Food Science and Human Wellness. 7, 2, p. 134-137 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • antineoplastic activity 100%
  • curcumin 92%
  • breast neoplasms 81%
  • Curcumin 81%
  • Neoplastic Stem Cells 76%
  79 引文 斯高帕斯（Scopus）

• Anti-cancer effects of CME-1, a novel polysaccharide, purified from the mycelia of Cordyceps sinensis against B16-F10 melanoma cells

  Jayakumar, T., Chiu, C. C., Wang, S. H., Chou, D. S., Huang, Y. K. & Sheu, J. R., 2014, 於: Journal of Cancer Research and Therapeutics. 10, 1, p. 43-49 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Cordyceps 100%
  • Mycelium 87%
  • Experimental Melanomas 81%
  • Polysaccharides 60%
  • Matrix Metalloproteinase 1 47%
  28 引文 斯高帕斯（Scopus）

• Antihypertensive and hypolipidemic effects of DC-015, a novel, potent and specific α1-adrenoceptor antagonist: Comparison with prazosin in spontaneously hypertensive rats

  Peng, I-H., Sheu, J-R., Chern, J-W., Lee, Y-M. & Yen, M-H., 1996, 於: Journal of Biomedical Science. 3, 2, p. 108-116 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  4 引文 斯高帕斯（Scopus）

• Anti-Inflammatory Mechanism of An Alkaloid Rutaecarpine in LTA-Stimulated RAW 264.7 Cells: Pivotal Role on NF-κB and ERK/p38 Signaling Molecules

  Jayakumar, T., Yang, C. M., Yen, T. L., Hsu, C. Y., Sheu, J. R., Hsia, C. W., Manubolu, M., Huang, W. C., Hsieh, C. Y. & Hsia, C. H., 6月 1 2022, 於: International journal of molecular sciences. 23, 11, 5889.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Alkaloids 98%
  • alkaloids 93%
  • Lipoteichoic Acid 87%
  • lipoteichoic acid 80%
  • Transcription factors 79%
  4 引文 斯高帕斯（Scopus）

• Anti-leukemic immunity against U937 cells in uremic patients

  Wu, C. J., Sheu, J. R., Chen, H. H., Shyur, S. D., Chen, P. G. & Chen, Y. J., 2003, 於: Neoplasma. 50, 1, p. 54-59 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • U937 Cells 100%
  • Phytohemagglutinins 89%
  • Immunity 64%
  • human CD68 antigen 20%
  • Renal Dialysis 19%

• Antioxidative and hepatoprotective effects of Antrodia camphorata extract

  Hsiao, G., Shen, M. Y., Lin, K. H., Lan, M. H., Wu, L. Y., Chou, D-S., Lin, C. H., Su, C-H. & Sheu, J-R., 5月 21 2003, 於: Journal of Agricultural and Food Chemistry. 51, 11, p. 3302-3308 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Antrodia 100%
  • Taiwanofungus camphoratus 96%
  • Hepatoprotective 82%
  • hepatoprotective effect 74%
  • Antioxidant Agent 44%
  207 引文 斯高帕斯（Scopus）

• Antiplatelet activity of a newly synthesized novel ruthenium (II): A potential role for Akt/JNK signaling

  Khamrang, T., Hung, K. C., Hsia, C. H., Hsieh, C. Y., Velusamy, M., Jayakumar, T. & Sheu, J. R., 5月 2017, 於: International journal of molecular sciences. 18, 5, 916.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Ruthenium 100%
  • Platelets 81%
  • Anticoagulant Agent 80%
  • ruthenium 77%
  • platelets 68%
  8 引文 斯高帕斯（Scopus）

• Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets

  Chen, T-G., Lee, J. J., Lin, K. H., Shen, C. H., Chou, D. S. & Sheu, J. R., 2007, 於: Chinese Journal of Physiology. 50, 3, p. 121-126 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • caffeic acid phenethyl ester 100%
  • Cyclic GMP 73%
  • Blood Platelets 49%
  • Phosphorylation 31%
  • vasodilator-stimulated phosphoprotein 28%
  21 引文 斯高帕斯（Scopus）

• Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway

  Sheu, J. R., Hsiao, G., Lee, C. R., Chang, W. C., Lee, L. W., Su, C-H. & Lin, C. H., 6月 1 2000, 於: Thrombosis Research. 99, 3, p. 249-258 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • lipoteichoic acid 100%
  • Cyclic AMP 67%
  • Staphylococcus aureus 59%
  • Blood Platelets 40%
  • Platelet Aggregation 17%
  5 引文 斯高帕斯（Scopus）

• Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production

  Jeng, J. H., Wu, H. L., Lin, B. R., Lan, W. H., Chang, H. H., Ho, Y. S., Lee, P. H., Wang, Y. J., Wang, J. S., Chen, Y. J. & Chang, M. C., 4月 2007, 於: Atherosclerosis. 191, 2, p. 250-258 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • sanguinarine 100%
  • Thromboxanes 73%
  • Calcium 40%
  • Arachidonic Acid 24%
  • Platelet Aggregation 24%
  54 引文 斯高帕斯（Scopus）

• Antithrombotic effect of PMC, a potent α-tocopherol analogue on platelet plug formation in vivo

  Hsiao, G., Yen, M. H., Lee, Y. M. & Sheu, J. R., 2002, 於: British Journal of Haematology. 117, 3, p. 699-704 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Tocopherols 100%
  • Bleeding Time 92%
  • Venules 60%
  • Blood Platelets 59%
  • 2,2,5,7,8-pentamethyl-6-hydroxychromane 55%
  14 引文 斯高帕斯（Scopus）

• Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments

  Sheu, J. R., Hung, W. C., Wu, C. H., Lee, Y. M. & Yen, M. H., 2000, 於: British Journal of Haematology. 110, 1, p. 110-115 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Evodia 95%
  • Alkaloids 61%
  • Blood Platelets 43%
  • Bleeding Time 25%
  • Venules 16%
  76 引文 斯高帕斯（Scopus）

• Antithrombotic effects of magnesium sulfate in in vivo experiments

  Sheu, J. R., Hsiao, G., Shen, M. Y., Lee, Y. M. & Yen, M. H., 5月 2003, 於: International Journal of Hematology. 77, 4, p. 414-419 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Magnesium Sulfate 100%
  • Bleeding Time 40%
  • Fluorescein 23%
  • Blood Platelets 17%
  • Mesenteric Arteries 13%
  7 引文 斯高帕斯（Scopus）

• Antithrombotic effects of tetramethylpyrazine in in vivo experiments

  Sheu, J. R., Hsiao, G., Lee, Y. M. & Yen, M. H., 4月 2001, 於: International Journal of Hematology. 73, 3, p. 393-398 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • tetramethylpyrazine 100%
  • Bleeding Time 34%
  • Venules 22%
  • Saline Solution 17%
  • Blood Platelets 14%
  18 引文 斯高帕斯（Scopus）

• Anti-tumor effect of hedgehog signaling inhibitor, vismodegib, on castration-resistant prostate cancer

  Ishii, A., Shigemura, K., Kitagawa, K., Sung, S. Y., Chen, K. C., Yi-Te, C., Liu, M. C. & Fujisawa, M., 9月 1 2020, 於: Anticancer Research. 40, 9, p. 5107-5114 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • HhAntag691 100%
  • Hedgehogs 80%
  • Castration 67%
  • Prostatic Neoplasms 48%
  • Epithelial-Mesenchymal Transition 31%
  9 引文 斯高帕斯（Scopus）

• Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest

  Wu, C. H., Jeng, J. H., Wang, Y. J., Tseng, C. J., Liang, Y. C., Chen, C. H., Lee, H. M., Lin, J. K., Lin, C. H., Lin, S. Y., Li, C. P. & Ho, Y. S., 4月 1 2002, 於: Toxicology and Applied Pharmacology. 180, 1, p. 22-35 14 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Miconazole 100%
  • G1 Phase Cell Cycle Checkpoints 86%
  • Nude Mice 62%
  • Antitumor 61%
  • Heterografts 59%
  32 引文 斯高帕斯（Scopus）

• Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of β-catenin/Notch1/Akt signaling

  Chen, J. H., T.H Wu, A., T.W Tzeng, D., Huang, C. C., Tzeng, Y. M. & Chao, T. Y., 1月 1 2019, 於: Phytomedicine. 52, p. 70-78 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • antrocin 100%
  • Antrodia 72%
  • Catenins 53%
  • Paclitaxel 50%
  • Carcinogenesis 32%
  14 引文 斯高帕斯（Scopus）

• Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway

  Lin, Y. S., Lin, Y. Y., Yang, Y. H., Lin, C. L., Kuan, F. C., Lu, C. N., Chang, G. H., Tsai, M. S., Hsu, C. M., Yeh, R. A., Yang, P. R., Lee, I. Y., Shu, L. H., Cheng, Y. C., Liu, H. T., Lee, K. D., Chang, D. C. & Wu, C. Y., 5月 9 2018, 於: BMC Complementary and Alternative Medicine. 18, 1, 152.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Antrodia 100%
  • S-Phase Kinase-Associated Proteins 95%
  • MicroRNAs 49%
  • Breast Neoplasms 37%
  • Apoptosis 35%
  27 引文 斯高帕斯（Scopus）

• Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression

  Su, Y. K., Shih, P. H., Lee, W. H., Bamodu, O. A., Wu, A. T. H., Huang, C. C., Tzeng, Y. M., Hsiao, M., Yeh, C. T. & Lin, C. M., 7月 31 2017, 於: Journal of Ethnopharmacology. 207, p. 47-56 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Antrodia 100%
  • MicroRNA 71%
  • Neoplastic Stem Cells 62%
  • Radio 59%
  • MicroRNAs 49%
  19 引文 斯高帕斯（Scopus）

• Antroquinonol D, isolated from Antrodia camphorata, with DNA demethylation and anticancer potential

  Wang, S. C., Li, Z-H., Hsu, C. H., Chang, Y. J., Chang, M. S., Wang, Y. C., Ho, Y. S., Wen, W. C. & Lin, R. K., 6月 18 2014, 於: Journal of Agricultural and Food Chemistry. 62, 24, p. 5625-5635 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • antroquinonol 100%
  • antroquinonols 99%
  • Antroquinonol 97%
  • Antrodia 81%
  • Taiwanofungus camphoratus 79%
  37 引文 斯高帕斯（Scopus）

• An undefined cystatin CsCPI1 from tea plant Camellia sinensis harbors antithrombotic activity

  Fang, M., Cha, J. H., Wang, H. C., Ye, P., Chen, B., Chen, M., Yang, W. H. & Yan, X., 3月 2023, 於: Biomedicine and Pharmacotherapy. 159, 114285.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Camellia sinensis 100%
  • Cystatins 97%
  • Tea 71%
  • Cardiovascular Diseases 35%
  • Therapeutic Uses 27%

• A parallel-arm randomized controlled trial to assess the effects of a far-infrared-emitting collar on neck disorder

  Lin, Y. S., Hung, K. S., Liau, B. Y., Yang, C. H., Yang, A. & Huang, K. S., 2015, 於: Materials. 8, 9, p. 5862-5876 15 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Infrared radiation 100%
  • Disorder 99%
  • disorders 89%
  • Muscle 64%
  • muscles 52%
  4 引文 斯高帕斯（Scopus）

• A personalized medication management platform (PMMP) to improve medication adherence: A randomized control trial

  Huang, C. Y., Nguyen, P. A. A., Clinciu, D. L., Hsu, C. K., Lu, J. C. R., Yang, H. C., Wu, C. C., Tsai, W. C., Chou, Y. C., Kuo, T. B. J., Chang, P. L., Jian, W. S. & Li, Y. C. J., 3月 1 2017, 於: Computer Methods and Programs in Biomedicine. 140, p. 275-281 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Medication Adherence 100%
  • Health 32%
  • Insurance 26%
  • Control Groups 24%
  • Costs and Cost Analysis 18%
  13 引文 斯高帕斯（Scopus）

• A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

  Changou, C. A., Shiah, H. S., Chen, L. T., Liu, S., Luh, F., Liu, S. H., Cheng, Y. C. & Yen, Y., 3月 2021, 於: Oncologist. 26, 3, p. e367-e373 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • PHY 906 100%
  • Capecitabine 59%
  • Hepatocellular Carcinoma 37%
  • Progression-Free Survival 14%
  • Safety 13%
  13 引文 斯高帕斯（Scopus）

• A phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients

  Hsu, H. C., Chou, W. C., Kuan, F. C., Lee, K. D., Rau, K. M., Huang, J. S. & Yang, T. S., 1月 1 2018, 於: Cancer Management and Research. 10, p. 6061-6070 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Leucovorin 100%
  • Colorectal Neoplasms 66%
  • Oxaliplatin 9%
  • Irinotecan 9%
  • Therapeutics 9%
  3 引文 斯高帕斯（Scopus）

• A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis

  Lee, Y. H., Tsai, Y. S., Chang, C. C., Ho, C. C., Shih, H. M., Chen, H. M., Lai, H. L., Lee, C. W., Lee, Y. C., Liao, Y. C., Yang, U. C., Cheng, T. H., Chern, Y. & Soong, B. W., 4月 2022, 於: Movement Disorders. 37, 4, p. 767-777 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • polyglutamine 100%
  • Proteostasis 99%
  • Huntington Disease 65%
  • Machado-Joseph Disease 25%
  • Huntingtin Protein 12%
  5 引文 斯高帕斯（Scopus）

• A pilot study for circadian gene disturbance in dementia patients

  Liu, H. C., Hu, C. J., Tang, Y. C. & Chang, J. G., 4月 25 2008, 於: Neuroscience Letters. 435, 3, p. 229-233 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Methylation 100%
  • Dementia 92%
  • CpG Islands 59%
  • Genes 44%
  • Lewy Body Disease 31%
  31 引文 斯高帕斯（Scopus）

• A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab

  Chang, T. K., Yin, T. C., Su, W. C., Tsai, H. L., Huang, C. W., Chen, Y. C., Li, C. C., Chen, P. J., Ma, C. J., Chuang, K. H., Cheng, T. L. & Wang, J. Y., 2020, 於: Oncology Research. 28, 7, p. 801-809 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Silymarin 100%
  • Irinotecan 85%
  • Bevacizumab 81%
  • Colorectal Neoplasms 57%
  • Diarrhea 40%
  3 引文 斯高帕斯（Scopus）

• A point mutation of integrin β₂ subunit blocks binding of α₅β₁ to fibronectin and invasin but not recruitment to adhesion plaques

  Takada, Y., Ylänne, J., Mandelman, D., Puzon, W. & Ginsberg, M. H., 11月 1992, 於: Journal of Cell Biology. 119, 4, p. 913-921 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Focal Adhesions 100%
  • Fibronectins 83%
  • Point Mutation 82%
  • Integrins 79%
  • Ligands 39%
  98 引文 斯高帕斯（Scopus）

• Apolipoprotein E4 allele is genetically associated with risk of the short- and medium-term postoperative cognitive dysfunction: A meta-analysis and trial sequential analysis

  Hsiao, W. J., Chen, C. Y., Kang, Y. N., Hu, C. J., Chen, C. H., Lin, P. L. & Lin, Y. C., 2月 2023, 於: PLoS ONE. 18, 2 February, e0282214.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Postoperative Cognitive Complications 100%
  • Apolipoprotein E4 92%
  • Meta-Analysis 50%
  • Alleles 49%
  • Delirium 39%

• A polymorphism of ORAI1 rs7135617, is associated with susceptibility to rheumatoid arthritis

  Yen, J. H., Chang, C. M., Hsu, Y. W., Lee, C. H., Wu, M. S., Hwang, D. Y., Chen, B. K., Liao, H. T., Wu, M. T. M. & Chang, W. C., 2014, 於: Mediators of Inflammation. 2014, 834831.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Rheumatoid Arthritis 100%
  • Single Nucleotide Polymorphism 40%
  • Genes 38%
  • Chronic Disease 35%
  • Immune System Diseases 25%
  21 引文 斯高帕斯（Scopus）

• Apoptosis signal-regulating kinase 1 in amyloid β peptide-induced cerebral endothelial cell apoptosis

  Hsu, M. J., Hsu, C-Y., Chen, B. C., Chen, M. C., Ou, G. & Lin, C. H., 5月 23 2007, 於: Journal of Neuroscience. 27, 21, p. 5719-5729 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • MAP Kinase Kinase Kinase 5 100%
  • Amyloid 60%
  • Endothelial Cells 46%
  • p38 Mitogen-Activated Protein Kinases 43%
  • Peptides 40%
  73 引文 斯高帕斯（Scopus）

• Apoptosis signal-regulating kinase 1 in peptidoglycan-induced COX-2 expression in macrophages

  Hsu, M. J., Chang, C. K., Chen, M. C., Chen, B. C., Ma, H. P., Hong, C-Y. & Lin, C. H., 6月 2010, 於: Journal of Leukocyte Biology. 87, 6, p. 1069-1082 14 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • MAP Kinase Kinase Kinase 5 100%
  • Peptidoglycan 76%
  • Transcription Factor AP-1 70%
  • Macrophages 44%
  • Luciferases 23%
  24 引文 斯高帕斯（Scopus）

• Apoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cells

  Kuo, C. T., Chen, B. C., Yu, C. C., Weng, C. M., Hsu, M. J., Chen, C. C., Chen, M. C., Teng, C. M., Pan, S. L., Bien, M. Y., Shih, C. H. & Lin, C. H., 2009, 於: Journal of Biomedical Science. 16, 1, 43.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • denbinobin 100%
  • MAP Kinase Kinase Kinase 5 72%
  • N-Acetyl-L-Cysteine 68%
  • Adenocarcinoma of Lung 49%
  • A549 Cells 31%
  33 引文 斯高帕斯（Scopus）

• Apoptotic neutrophils undergoing secondary necrosis induce human lung epithelial cell detachment

  Liu, C. Y., Liu, Y. H., Lin, S. M., Yu, C. T., Wang, C. H., Lin, H. C., Lin, C. H. & Kuo, H. P., 2003, 於: Journal of Biomedical Science. 10, 6 II, p. 746-756 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Apoptotic 100%
  • Neutrophils 68%
  • Necrosis 67%
  • Epithelial Cells 62%
  • Serine 49%
  40 引文 斯高帕斯（Scopus）

• A population-based five-year study on the risk of stroke in patients with osteoporosis in Taiwan

  Lin, C. H., Chang, W. C., Kuo, C. N., Yu, H. C., Yang, C. C., Lin, Y. W., Hung, K. S. & Chang, W. P., 3月 1 2015, 於: Bone. 72, p. 9-13 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Taiwan 100%
  • Osteoporosis 89%
  • Stroke 69%
  • Population 39%
  • Survival Rate 21%
  8 引文 斯高帕斯（Scopus）

• A potent antioxidant, lycopene, affords neuroprotection against microglia activation and focal cerebral ischemia in rats

  Hsiao, G., Fong, T. H., Tzu, N. H., Lin, K. H., Chou, D. S. & Sheu, J. R., 5月 2004, 於: In Vivo. 18, 3, p. 351-356 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Lycopene 100%
  • Neuroprotection 74%
  • Microglia 71%
  • Brain Ischemia 70%
  • Antioxidant Agent 54%
  95 引文 斯高帕斯（Scopus）